What is the role of histologic and molecular marker analysis in the workup of metastatic and advanced prostate cancer?

Updated: Dec 29, 2020
  • Author: Martha K Terris, MD, FACS; Chief Editor: Edward David Kim, MD, FACS  more...
  • Print


Certain molecular markers, such as E-cadherin, p53 and p21, DNA ploidy analysis, human kallikrein 2, and microvessel density (histologic marker of tumor angiogenesis) are also being evaluated to help characterize disease progression.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!